The cell and gene supply chain is a critical component of the biotechnology industry, comprising multiple stages from raw material sourcing to final product delivery. The complexity of this supply chain is attributed to the sensitive nature of biological materials, stringent regulatory requirements, and the need for precise temperature control, tracking, and documentation. Ensuring the integrity and quality of cell and gene therapies throughout the supply chain requires robust inventory management, rigorous testing and validation protocols, and efficient communication among stakeholders to prevent contamination, mislabeling, and other potential issues.